1. Home
  2. IOVA
  3. IOVA News

Latest Iovance Biotherapeutics Inc. (IOVA) News on May 9, 2025

Iovance Biotherapeutics (NasdaqGM:IOVA) Sees 3% Price Increase Over Last Month
IOVA

Simply Wall St.

2 days ago

Iovance Biotherapeutics (NasdaqGM:IOVA) Sees 3% Price Increase Over Last Month

My 3 Favorite Stocks to Buy Right Now
IOVA

Motley Fool

3 days ago

My 3 Favorite Stocks to Buy Right Now

Iovance Biotherapeutics to Host First Quarter 2025 Financial Results and Corporate Updates Webcast on Thursday, May 8, 2025
IOVA

GlobeNewswire

6 days ago

Iovance Biotherapeutics to Host First Quarter 2025 Financial Results and Corporate Updates Webcast on Thursday, May 8, 2025

Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) Is Expected To Breakeven In The Near Future
IOVA

Simply Wall St.

7 days ago

Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) Is Expected To Breakeven In The Near Future

2 Beaten-Down Stocks With Incredible Upside Potential
IOVA

Motley Fool

9 days ago

2 Beaten-Down Stocks With Incredible Upside Potential

Iovance Biotherapeutics Announces Participation in Upcoming Scientific Congresses
IOVA

GlobeNewswire

15 days ago

Iovance Biotherapeutics Announces Participation in Upcoming Scientific Congresses

Iovance Biotherapeutics Stock Is Crashing. And Here's Why Things Could Get Even Worse This Year.
IOVA

Motley Fool

16 days ago

Iovance Biotherapeutics Stock Is Crashing. And Here's Why Things Could Get Even Worse This Year.

This Biotech Stock Could Be the Best Investment of the Decade
IOVA

Motley Fool

20 days ago

This Biotech Stock Could Be the Best Investment of the Decade

Is Iovance Biotherapeutics (IOVA) the Most Promising Penny Stock According to Analysts?
IOVA

Insider Monkey

20 days ago

Is Iovance Biotherapeutics (IOVA) the Most Promising Penny Stock According to Analysts?

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
IOVA

GlobeNewswire

20 days ago

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

Is Iovance Biotherapeutics Inc. (NASDAQ:IOVA) the Best Biotech Penny Stock to Buy According to Hedge Funds?
IOVA

Insider Monkey

23 days ago

Is Iovance Biotherapeutics Inc. (NASDAQ:IOVA) the Best Biotech Penny Stock to Buy According to Hedge Funds?

Is Iovance Biotherapeutics a Millionaire-Maker?
IOVA

Motley Fool

25 days ago

Is Iovance Biotherapeutics a Millionaire-Maker?

Iovance Biotherapeutics, Inc. (IOVA): Among Stocks Under $10 that Will Triple
IOVA

Insider Monkey

a month ago

Iovance Biotherapeutics, Inc. (IOVA): Among Stocks Under $10 that Will Triple

4 Beaten-Down Stocks That Could Skyrocket by 50% to 543%, According to Wall Street
IOVA

Motley Fool

a month ago

4 Beaten-Down Stocks That Could Skyrocket by 50% to 543%, According to Wall Street

Iovance Biotherapeutics (NasdaqGM:IOVA) Drops 10% Over The Week In Market Correction
IOVA

Simply Wall St.

a month ago

Iovance Biotherapeutics (NasdaqGM:IOVA) Drops 10% Over The Week In Market Correction

Traws Pharma Announces Management Updates
IOVA

GlobeNewswire

a month ago

Traws Pharma Announces Management Updates

Is Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) The Top Penny Stock That Will Skyrocket?
IOVA

Insider Monkey

a month ago

Is Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) The Top Penny Stock That Will Skyrocket?

1 Stock Worth Buying Near Its 52-Week Low, According to Wall Street
IOVA

Motley Fool

2 months ago

1 Stock Worth Buying Near Its 52-Week Low, According to Wall Street

3 Growth Stocks Wall Street Might Be Sleeping On -- But I'm Not
IOVA

Motley Fool

2 months ago

3 Growth Stocks Wall Street Might Be Sleeping On -- But I'm Not

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
IOVA

GlobeNewswire

2 months ago

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

Is Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) the Most Oversold Penny Stocks to Buy According to Analysts?
IOVA

Insider Monkey

2 months ago

Is Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) the Most Oversold Penny Stocks to Buy According to Analysts?

Down Nearly 80% From Its High, Is Iovance Biotherapeutics Stock Too Cheap to Pass Up?
IOVA

Motley Fool

2 months ago

Down Nearly 80% From Its High, Is Iovance Biotherapeutics Stock Too Cheap to Pass Up?

Iovance Biotherapeutics (NasdaqGM:IOVA) Stock Dips 27% Despite Reaffirmed 2025 Earnings Guidance
IOVA

Simply Wall St.

2 months ago

Iovance Biotherapeutics (NasdaqGM:IOVA) Stock Dips 27% Despite Reaffirmed 2025 Earnings Guidance

Iovance Biotherapeutics price target lowered to $30 from $34 at Chardan
IOVA

TipRanks

2 months ago

Iovance Biotherapeutics price target lowered to $30 from $34 at Chardan

IOVA

MT Newswires

2 months ago

Chardan Cuts Price Target on Iovance Biotherapeutics to $30 From $34, Keeps Buy Rating

Iovance Biotherapeutics Full Year 2024 Earnings: EPS Misses Expectations
IOVA

Simply Wall St.

2 months ago

Iovance Biotherapeutics Full Year 2024 Earnings: EPS Misses Expectations

IOVA

MT Newswires

2 months ago

Truist Adjusts Price Target on Iovance Biotherapeutics to $15 From $25, Maintains Buy Rating

IOVA Q4 Earnings Beat, Stock Down on Looming Economic Uncertainty
IOVA

Zacks

2 months ago

IOVA Q4 Earnings Beat, Stock Down on Looming Economic Uncertainty

IOVA

MT Newswires

2 months ago

Iovance Biotherapeutics Q4 Loss Narrows, Revenue Rises

Iovance Biotherapeutics Inc (IOVA) Q4 2024 Earnings Call Highlights: Strong Revenue and ...
IOVA

GuruFocus.com

2 months ago

Iovance Biotherapeutics Inc (IOVA) Q4 2024 Earnings Call Highlights: Strong Revenue and ...

Iovance Biotherapeutics (IOVA) Reports Q4 Loss, Tops Revenue Estimates
IOVA

Zacks

2 months ago

Iovance Biotherapeutics (IOVA) Reports Q4 Loss, Tops Revenue Estimates

IOVA

Associated Press Finance

2 months ago

Iovance Biotherapeutics: Q4 Earnings Snapshot

Iovance Biotherapeutics Reports Financial Results and Corporate Updates for Fourth Quarter and Full Year 2024
IOVA

GlobeNewswire

2 months ago

Iovance Biotherapeutics Reports Financial Results and Corporate Updates for Fourth Quarter and Full Year 2024

What's in Store for These 5 Biotech Stocks This Earnings Season?
IOVA

Zacks

2 months ago

What's in Store for These 5 Biotech Stocks This Earnings Season?

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
IOVA

GlobeNewswire

3 months ago

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

Will Iovance Biotherapeutics (IOVA) Report Negative Earnings Next Week? What You Should Know
IOVA

Zacks

3 months ago

Will Iovance Biotherapeutics (IOVA) Report Negative Earnings Next Week? What You Should Know

Iovance Biotherapeutics to Report Fourth Quarter and Full Year 2024 Financial Results and Corporate Updates on February 27, 2025
IOVA

GlobeNewswire

3 months ago

Iovance Biotherapeutics to Report Fourth Quarter and Full Year 2024 Financial Results and Corporate Updates on February 27, 2025

High Growth Tech Stocks In The United States To Watch
IOVA

Simply Wall St.

3 months ago

High Growth Tech Stocks In The United States To Watch

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
IOVA

GlobeNewswire

3 months ago

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

Iovance Biotherapeutics Appoints Dan Kirby as Chief Commercial Officer
IOVA

GlobeNewswire

3 months ago

Iovance Biotherapeutics Appoints Dan Kirby as Chief Commercial Officer

What's Wrong With Iovance Biotherapeutics Stock?
IOVA

Motley Fool

3 months ago

What's Wrong With Iovance Biotherapeutics Stock?

Where Will Iovance Biotherapeutics Be in 5 Years?
IOVA

Motley Fool

3 months ago

Where Will Iovance Biotherapeutics Be in 5 Years?

Meet the Growth Stock That Could Soar 280%, According to Wall Street Analysts
IOVA

Motley Fool

3 months ago

Meet the Growth Stock That Could Soar 280%, According to Wall Street Analysts

Insider Stock Buying Reaches US$48.3m On Iovance Biotherapeutics
IOVA

Simply Wall St.

3 months ago

Insider Stock Buying Reaches US$48.3m On Iovance Biotherapeutics

Is Iovance Biotherapeutics (IOVA) Among Billionaire Joseph Edelman’s Long-Term Stock Picks?
IOVA

Insider Monkey

4 months ago

Is Iovance Biotherapeutics (IOVA) Among Billionaire Joseph Edelman’s Long-Term Stock Picks?

3 Stocks That Could Turn $1,000 Into $5,000 by 2030
IOVA

Motley Fool

4 months ago

3 Stocks That Could Turn $1,000 Into $5,000 by 2030

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
IOVA

GlobeNewswire

4 months ago

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

3 Mid-Cap Stocks That Could Take Off in 2025
IOVA

Motley Fool

4 months ago

3 Mid-Cap Stocks That Could Take Off in 2025

Exploring 3 High Growth Tech Stocks In The United States
IOVA

Simply Wall St.

4 months ago

Exploring 3 High Growth Tech Stocks In The United States

Why Iovance Biotherapeutics Stock Zoomed More Than 5% Higher Today
IOVA

Motley Fool

4 months ago

Why Iovance Biotherapeutics Stock Zoomed More Than 5% Higher Today

Why Iovance Biotherapeutics Inc. (IOVA) Is Skyrocketing
IOVA

Insider Monkey

4 months ago

Why Iovance Biotherapeutics Inc. (IOVA) Is Skyrocketing

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
IOVA

GlobeNewswire

5 months ago

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

If I Could Only Buy 3 Stocks in the Last Month of 2024, I'd Pick These
IOVA

Motley Fool

5 months ago

If I Could Only Buy 3 Stocks in the Last Month of 2024, I'd Pick These

2 Growth Stocks That Could Rocket Higher in 2025: Are They Right for Your Portfolio?
IOVA

Motley Fool

5 months ago

2 Growth Stocks That Could Rocket Higher in 2025: Are They Right for Your Portfolio?

Prediction: This Stock Will Beat the Market in 2025
IOVA

Motley Fool

5 months ago

Prediction: This Stock Will Beat the Market in 2025

3 Monster Stocks to Hold for the Next 10 Years
IOVA

Motley Fool

5 months ago

3 Monster Stocks to Hold for the Next 10 Years

Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) is a favorite amongst institutional investors who own 63%
IOVA

Simply Wall St.

5 months ago

Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) is a favorite amongst institutional investors who own 63%

Is Iovance Biotherapeutics Stock a Millionaire Maker?
IOVA

Motley Fool

5 months ago

Is Iovance Biotherapeutics Stock a Millionaire Maker?

IOVA

MT Newswires

5 months ago

Iovance Biotherapeutics Names Raj Puri as Chief Regulatory Officer

Iovance Biotherapeutics Announces the Promotion of Raj Puri, M.D., Ph.D. to Chief Regulatory Officer
IOVA

GlobeNewswire

5 months ago

Iovance Biotherapeutics Announces the Promotion of Raj Puri, M.D., Ph.D. to Chief Regulatory Officer

Got $1,500? Buy Iovance Biotherapeutics Now and Don't Look Back
IOVA

Motley Fool

6 months ago

Got $1,500? Buy Iovance Biotherapeutics Now and Don't Look Back

Iovance Biotherapeutics, Inc. (IOVA): Among the Most Promising Cancer Stocks According to Hedge Funds
IOVA

Insider Monkey

6 months ago

Iovance Biotherapeutics, Inc. (IOVA): Among the Most Promising Cancer Stocks According to Hedge Funds

2 Innovative Stocks That Could Deliver Outsize Returns
IOVA

Motley Fool

6 months ago

2 Innovative Stocks That Could Deliver Outsize Returns

Iovance Biotherapeutics Inc. (IOVA): Among the NASDAQ Stocks with Biggest Upside Potential According to Analysts
IOVA

Insider Monkey

6 months ago

Iovance Biotherapeutics Inc. (IOVA): Among the NASDAQ Stocks with Biggest Upside Potential According to Analysts

Iovance Biotherapeutics Third Quarter 2024 Earnings: Beats Expectations
IOVA

Simply Wall St.

6 months ago

Iovance Biotherapeutics Third Quarter 2024 Earnings: Beats Expectations

Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) Third-Quarter Results: Here's What Analysts Are Forecasting For Next Year
IOVA

Simply Wall St.

6 months ago

Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) Third-Quarter Results: Here's What Analysts Are Forecasting For Next Year

IOVA Posts Narrower-Than-Expected Q3 Loss, Amtagvi Sales Drive Top line
IOVA

Zacks

6 months ago

IOVA Posts Narrower-Than-Expected Q3 Loss, Amtagvi Sales Drive Top line

Iovance Biotherapeutics Inc (IOVA) Q3 2024 Earnings Call Highlights: Surpassing Revenue ...
IOVA

GuruFocus.com

6 months ago

Iovance Biotherapeutics Inc (IOVA) Q3 2024 Earnings Call Highlights: Surpassing Revenue ...

Iovance Biotherapeutics (IOVA) Reports Q3 Loss, Tops Revenue Estimates
IOVA

Zacks

6 months ago

Iovance Biotherapeutics (IOVA) Reports Q3 Loss, Tops Revenue Estimates

IOVA

Associated Press Finance

6 months ago

Iovance Biotherapeutics: Q3 Earnings Snapshot

Iovance Biotherapeutics Reports Financial Results and Corporate Updates for Third Quarter and Year to Date 2024
IOVA

GlobeNewswire

6 months ago

Iovance Biotherapeutics Reports Financial Results and Corporate Updates for Third Quarter and Year to Date 2024

High Growth Tech Stocks to Watch in November 2024
IOVA

Simply Wall St.

6 months ago

High Growth Tech Stocks to Watch in November 2024

Iovance Biotherapeutics to Host Third Quarter and Year-to-Date 2024 Financial Results Conference Call and Webcast on Thursday, November 7, 2024
IOVA

GlobeNewswire

6 months ago

Iovance Biotherapeutics to Host Third Quarter and Year-to-Date 2024 Financial Results Conference Call and Webcast on Thursday, November 7, 2024

Why Iovance Biotherapeutics Stock Triumphed on Thursday
IOVA

Motley Fool

6 months ago

Why Iovance Biotherapeutics Stock Triumphed on Thursday

IOVA

MT Newswires

6 months ago

UBS Initiates Iovance Biotherapeutics With Buy Rating, $17 Price Target

State Street Corp's Strategic Acquisition in Iovance Biotherapeutics Inc
IOVA

GuruFocus.com

7 months ago

State Street Corp's Strategic Acquisition in Iovance Biotherapeutics Inc

Is Iovance Biotherapeutics Inc. (IOVA) the Most Promising Stock to Buy According to Wall Street Analysts?
IOVA

Insider Monkey

7 months ago

Is Iovance Biotherapeutics Inc. (IOVA) the Most Promising Stock to Buy According to Wall Street Analysts?

Is Iovance Biotherapeutics, Inc. (IOVA) the Best Growth Stock Under $10 to Buy?
IOVA

Insider Monkey

7 months ago

Is Iovance Biotherapeutics, Inc. (IOVA) the Best Growth Stock Under $10 to Buy?

Is Iovance Biotherapeutics, Inc. (IOVA) the Best Stock Under $10 With High Potential?
IOVA

Insider Monkey

7 months ago

Is Iovance Biotherapeutics, Inc. (IOVA) the Best Stock Under $10 With High Potential?

Strong Investor Sentiment: Artisan Partners Highlights Iovance Biotherapeutics, Inc. (IOVA)
IOVA

Insider Monkey

7 months ago

Strong Investor Sentiment: Artisan Partners Highlights Iovance Biotherapeutics, Inc. (IOVA)

Is Iovance Biotherapeutics Stock a Buy?
IOVA

Motley Fool

7 months ago

Is Iovance Biotherapeutics Stock a Buy?

High Growth Tech Stocks to Watch in October 2024
IOVA

Simply Wall St.

7 months ago

High Growth Tech Stocks to Watch in October 2024

3 Reasons to Buy Iovance Biotherapeutics Stock Like There's No Tomorrow
IOVA

Motley Fool

7 months ago

3 Reasons to Buy Iovance Biotherapeutics Stock Like There's No Tomorrow

Iovance Biotherapeutics (NASDAQ:IOVA) delivers shareholders favorable 74% return over 1 year, surging 4.9% in the last week alone
IOVA

Simply Wall St.

8 months ago

Iovance Biotherapeutics (NASDAQ:IOVA) delivers shareholders favorable 74% return over 1 year, surging 4.9% in the last week alone

3 Things You Need to Know if You Buy Iovance Biotherapeutics Today
IOVA

Motley Fool

8 months ago

3 Things You Need to Know if You Buy Iovance Biotherapeutics Today

Iovance Biotherapeutics, Inc. (IOVA): Short Seller Sentiment is Bearish on This Cancer Stock
IOVA

Insider Monkey

8 months ago

Iovance Biotherapeutics, Inc. (IOVA): Short Seller Sentiment is Bearish on This Cancer Stock

Alimera Sciences (ALIM) Soars 6.6%: Is Further Upside Left in the Stock?
IOVA

Zacks

8 months ago

Alimera Sciences (ALIM) Soars 6.6%: Is Further Upside Left in the Stock?

This Is the Biggest Risk With Iovance Biotherapeutics Stock
IOVA

Motley Fool

8 months ago

This Is the Biggest Risk With Iovance Biotherapeutics Stock

Iovance Biotherapeutics to Present at Upcoming Conferences
IOVA

GlobeNewswire

8 months ago

Iovance Biotherapeutics to Present at Upcoming Conferences

3 Monster Biotech Stocks to Buy Before 2025
IOVA

Motley Fool

8 months ago

3 Monster Biotech Stocks to Buy Before 2025

Up 47% in 2024: Where Will Iovance Biotherapeutics Be in 5 Years?
IOVA

Motley Fool

8 months ago

Up 47% in 2024: Where Will Iovance Biotherapeutics Be in 5 Years?

High Growth Tech Stocks To Watch In August 2024
IOVA

Simply Wall St.

8 months ago

High Growth Tech Stocks To Watch In August 2024

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
IOVA

GlobeNewswire

9 months ago

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

This 1 Big Risk Is Also 1 Big Opportunity for Iovance Biotherapeutics Stock
IOVA

Motley Fool

9 months ago

This 1 Big Risk Is Also 1 Big Opportunity for Iovance Biotherapeutics Stock

Industry Analysts Just Made A Sizeable Upgrade To Their Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) Revenue Forecasts
IOVA

Simply Wall St.

9 months ago

Industry Analysts Just Made A Sizeable Upgrade To Their Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) Revenue Forecasts

3 US Growth Companies With High Insider Ownership Growing Earnings Up To 68%
IOVA

Simply Wall St.

9 months ago

3 US Growth Companies With High Insider Ownership Growing Earnings Up To 68%

Iovance Biotherapeutics Second Quarter 2024 Earnings: Beats Expectations
IOVA

Simply Wall St.

9 months ago

Iovance Biotherapeutics Second Quarter 2024 Earnings: Beats Expectations

Why Iovance Biotherapeutics Shares Are Soaring Today
IOVA

Motley Fool

9 months ago

Why Iovance Biotherapeutics Shares Are Soaring Today

Iovance (IOVA) Q2 Earnings Beat, Stock Up on Upbeat Sales View
IOVA

Zacks

9 months ago

Iovance (IOVA) Q2 Earnings Beat, Stock Up on Upbeat Sales View

Iovance Biotherapeutics (IOVA) Reports Q2 Loss, Tops Revenue Estimates
IOVA

Zacks

9 months ago

Iovance Biotherapeutics (IOVA) Reports Q2 Loss, Tops Revenue Estimates

Share on Social Networks: